Published on 7 May 2024 on Benzinga
Following the recent move on the part of the DEA toward
reclassifying cannabis from Schedule I to Schedule III, Zuanic & Associates hosted discussions with industry leaders to assess the impact and outline the next steps. The comprehensive review indicates there could be significant regulatory moves and potential financial implications for the cannabis industry.